These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 33950779

  • 1. Intratympanic gentamicin injection for refractory ménière's disease (MD) has potential effect in preventing contralateral MD occurrence.
    Wu Y, Zhou Y, Yu J, Song Z, Dai C, Wang J.
    Acta Otolaryngol; 2021 Jul; 141(7):657-662. PubMed ID: 33950779
    [Abstract] [Full Text] [Related]

  • 2. Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials.
    Celis-Aguilar E, Hinojosa-González R, Vales-Hidalgo O, Coutinho-Toledo H.
    Braz J Otorhinolaryngol; 2016 Jul; 82(6):668-673. PubMed ID: 27068887
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 5. Clinical features and management of Meniere's disease patients with drop attacks.
    Wu Q, Li X, Sha Y, Dai C.
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):665-672. PubMed ID: 30604056
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC, Han JJ, Park J, Choi BY, Koo JW.
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
    Okuda H, Aoki M, Ogawa B, Shibata H, Ueda N, Ohashi T, Hayashi H, Nishihori T, Kuze B, Ogawa T.
    Am J Otolaryngol; 2021 Apr; 42(6):103141. PubMed ID: 34171697
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and preservation of hearing with low-dose gentamicin in unilateral meniere's disease: A clinical symptomatology-based study.
    Scarpa A, Avallone E, Carucci M, Salzano G, Chiarella G, Cassandro C, Viola P, Ricciardiello F, Ralli M, De Luca P, Salzano FA.
    Am J Otolaryngol; 2024 Apr; 45(1):104116. PubMed ID: 37984050
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 16. End-point indicators of low-dose intra-tympanic gentamicin in management of Ménière's disease.
    Liu H, Zhang T, Wu Q, Zhang Y, Dai C.
    Acta Otolaryngol; 2017 Feb; 137(2):136-143. PubMed ID: 27608722
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY, Kim YS, Jeong B, Carandang M, Koo JW, Oh SH, Lee JH.
    Am J Otolaryngol; 2021 Feb; 42(6):103086. PubMed ID: 34098455
    [Abstract] [Full Text] [Related]

  • 18. [Intratympanic gentamicin in Menière's disease].
    Huang W, Xu H, Gao B.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.